Synjardy is a prescription medication that combines two active ingredients, empagliflozin (12.5 mg) and metformin hydrochloride (1000 mg). It is commonly used to manage type 2 diabetes.Empagliflozin (12.5 mg): This is a medication known as an SGLT2 (sodium-glucose cotransporter 2) inhibitor. It works by blocking a protein in the kidneys that helps reabsorb glucose from the urine back into the bloodstream. This helps the kidneys remove excess glucose through urine, lowering blood sugar levels.Metformin (1000 mg): Metformin is a type of drug known as a biguanide. It works by decreasing the amount of sugar produced by the liver and increasing the body's sensitivity to insulin, which helps improve the body’s ability to use glucose effectively.Synjardy is typically prescribed for people with type 2 diabetes to improve blood sugar control. It is usually prescribed when diet and exercise alone aren't enough to manage blood sugar. It can also be used in combination with other medications like insulin or sulfonylureas, depending on the individual's needs.